HEART FAILURE

M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer, A.B. Cropp, D.L. DeMets, "Effect of amlodipine on morbidity and mortality in severe chronic heart failure," New England Journal of Medicine, 335:1107-14, 1996. (Cited in more than 155 papers since publication) Comments by Christopher Michael O'Connor, associate director of the Duke Clinical Research Institute, Durham, N.C. Medical advances have allowed us to live

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

M. Packer, C.M. O'Connor, J.K. Ghali, M.L. Pressler, P.E. Carson, R.N. Belkin, A.B. Miller, G.W. Neuberg, D. Frid, J.H. Wertheimer, A.B. Cropp, D.L. DeMets, "Effect of amlodipine on morbidity and mortality in severe chronic heart failure," New England Journal of Medicine, 335:1107-14, 1996. (Cited in more than 155 papers since publication)

Comments by Christopher Michael O'Connor, associate director of the Duke Clinical Research Institute, Durham, N.C.

Medical advances have allowed us to live longer and granted a higher quality of life, but they can also lead to other problems. While heart disease in general is on the decline, heart failure--or a buildup of fluid in the lungs due to a weakening heart--is actually becoming more common.

Patients usually develop heart failure in one of two ways: as a result of hypertension, or as a result of a heart attack. "We've made great strides in reduction of risk factors for hypertension, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Christopher Michael O'connor

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo